Amicus Therapeutics Inc (FOLD) Insider Trading
- $71,123,425.77
- $144,556,539.95
- March 5, 2024
- John F Crowley
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| April 15, 2015 | Director | 20,000 | $12.50 | Sell | $250,000.00 | |
| April 15, 2015 | VP | 5,000 | $12.50 | Sell | $62,500.00 | |
| April 10, 2015 | CEO | 11,678 | $12.00 | Sell | $140,136.00 | |
| April 1, 2015 | VP | 9,489 | $10.69 | Sell | $101,437.41 | |
| Jan. 5, 2015 | VP | 4,667 | $9.00 | Sell | $42,003.00 | |
| Dec. 4, 2014 | CEO | 89,000 | $8.36 | Sell | $744,040.00 | |
| Nov. 25, 2014 | COO | 7,250 | $8.00 | Sell | $58,000.00 | |
| Nov. 25, 2014 | CFO | 10,000 | $8.00 | Sell | $80,000.00 | |
| Nov. 25, 2014 | VP | 8,103 | $8.00 | Sell | $64,824.00 | |
| Nov. 19, 2014 | Major Shareholder | 2,100,000 | $6.50 | Buy | $13,650,000.00 | |
| Oct. 27, 2014 | Major Shareholder | 11,315,825 | $5.29 | Sell | $59,860,714.25 | |
| Oct. 3, 2014 | VP | 8,552 | $7.00 | Sell | $59,864.00 | |
| Oct. 3, 2014 | CFO | 10,000 | $7.00 | Sell | $70,000.00 | |
| Oct. 2, 2014 | VP | 4,759 | $5.99 | Sell | $28,506.41 | |
| Sept. 29, 2014 | CFO | 25,311 | $6.09 | Sell | $154,143.99 | |
| Sept. 29, 2014 | VP | 10,738 | $6.10 | Sell | $65,501.80 | |
| Aug. 27, 2014 | VP | 5,000 | $7.00 | Sell | $35,000.00 | |
| Aug. 27, 2014 | Director | 10,000 | $6.50 | Sell | $65,000.00 | |
| Aug. 25, 2014 | VP | 5,000 | $6.00 | Sell | $30,000.00 | |
| Aug. 25, 2014 | COO | 7,000 | $6.00 | Sell | $42,000.00 | |
| Aug. 20, 2014 | VP | 12,810 | $5.40 | Sell | $69,174.00 | |
| Aug. 20, 2014 | COO | 18,750 | $5.40 | Sell | $101,250.00 | |
| June 30, 2014 | Major Shareholder | 4,000,000 | $3.50 | Buy | $14,000,000.00 | |
| Nov. 20, 2013 | major shareholder | 1,500,000 | $2.00 | Buy | $3,000,000.00 | |
| March 15, 2013 | Director | 25,000 | $3.40 | Buy | $85,000.00 | |
| Nov. 13, 2012 | SVP | 1,665 | $4.54 | Buy | $7,559.10 |
Insiders are both buying and selling Amicus Therapeutics Inc stock.
The insider traders at Amicus Therapeutics Inc are: John F Crowley, Bradley L Campbell, Jay Barth, Hung Do, Burke W Whitman, Daphne Quimi, William D Baird III, Perceptive Advisors Llc, Ellen Rosenberg, Jeff Castelli, Samantha Prout, Margaret G Mcglynn, Michael Raab, David Michael Clark, Life Sciences Maste Perceptive, Kenneth Peist, Jayne Gershkowitz, Glenn Sblendorio, Julie Yu, Donald J Hayden Jr, Kurt J Andrews, Plc Glaxosmithkline, Ken Valenzano, Bradley L. Campbell, Enrique Dilone, William D. Baird III, Burke W. Whitman, Dipal Doshi, Joan Winterbottom, John F. Crowley, Lynn Dorsey Bleil, and Sol J Barer
The most active insider trader at Amicus Therapeutics Inc is John F Crowley with 110 trades.
Plc Glaxosmithkline has sold the most Amicus Therapeutics Inc stock with a total value of $119,721,428.50.
Perceptive Advisors Llc has bought the most Amicus Therapeutics Inc stock with a total value of $40,474,740.62.
The most recent insider trade for Amicus Therapeutics Inc was on March 5, 2024.
The single biggest insider buy for Amicus Therapeutics Inc was from Life Sciences Maste Perceptive with a total value of $18,375,000.00 on July 13, 2017.
The single biggest insider sell for Amicus Therapeutics Inc was from Plc Glaxosmithkline with a total value of $59,860,714.25 on Oct. 27, 2014.